Also trades as: DHR-PA (NYSE) · $vol 45M · DHR-PB (NYSE) · $vol 16M · 0R2B.L (LSE) · $vol 6M · DAP.DE (XETRA) · $vol 0M

$172.00

-1.33 (-0.77%)

Weekly Expected Move ±3.6%

$150 $156 $162 $168 $174

NYSE · Healthcare · Medical - Diagnostics & Research · Alpha Radar Neutral · Power 45 · $121.7B mcap · 631M float · 0.750% daily turnover · Short 29% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$24.6B +2.9% ▲

5Y CAGR: +2.0%

Gross Profit

$15.0B +5.4% ▲

5Y CAGR: +3.7%

Operating Income

$5.1B -0.9% ▼

5Y CAGR: +3.6%

Net Income

$3.6B -7.3% ▼

5Y CAGR: -0.2%

EPS (Diluted)

$5.04 -4.7% ▼

5Y CAGR: +0.6%

EBITDA

$6.9B -4.5% ▼

5Y CAGR: +1.2%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$29.5B	$26.6B	$23.9B	$23.9B	$24.6B
YoY Growth	+32.2%	-9.5%	-10.3%	-0.1%	+2.9%
Cost of Revenue	$11.5B	$10.5B	$9.9B	$9.7B	$9.6B
Gross Profit	$18.0B	$16.2B	$14.0B	$14.2B	$15.0B
Gross Margin	61.0%	60.8%	58.7%	59.5%	60.9%
R&D Expenses	$1.7B	$1.5B	$1.5B	$1.6B	$1.6B
SG&A Expenses	$8.2B	$7.1B	$7.3B	$7.4B	$8.2B
Operating Expenses	$9.9B	$8.7B	$8.8B	$9.0B	$9.8B
Operating Income	$8.1B	$7.5B	$5.3B	$5.2B	$5.1B
Operating Margin	27.3%	28.3%	22.1%	21.7%	20.9%
Interest Expense	$241M	$207M	$289M	$278M	$265M
Income Before Tax	$7.6B	$7.1B	$5.0B	$4.6B	$4.2B
Tax Expense	$1.3B	$818M	$823M	$747M	$619M
Net Income	$6.4B	$7.2B	$4.8B	$3.9B	$3.6B
Net Margin	21.8%	27.1%	19.9%	16.3%	14.7%
EPS (Diluted)	$8.61	$9.64	$6.38	$5.29	$5.04
EBITDA	$10.0B	$9.5B	$7.5B	$7.3B	$6.9B
Shares Outstanding	737M	737M	743M	737M	711M

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$5.7B	$5.8B	$6.5B	$5.7B	$5.9B	$6.1B	$6.8B	$6.0B
Cost of Revenue	$2.3B	$2.4B	$2.6B	$2.2B	$2.0B	$2.5B	$2.9B	$2.4B
Gross Profit	$3.4B	$3.4B	$3.9B	$3.5B	$4.0B	$3.5B	$4.0B	$3.6B
Gross Margin	59.7%	58.7%	59.5%	61.4%	66.6%	58.2%	58.0%	60.3%
R&D Expenses	$391M	$383M	$442M	$379M	$403M	$378M	$438M	$387M
SG&A Expenses	$1.9B	$2.1B	$1.7B	$1.9B	$2.4B	$2.0B	$2.0B	$1.9B
Operating Expenses	$2.3B	$2.4B	$2.1B	$2.2B	$2.8B	$2.4B	$2.5B	$2.2B
Operating Income	$1.2B	$958M	$1.7B	$1.3B	$1.2B	$1.2B	$1.5B	$1.3B
Operating Margin	20.3%	16.5%	26.7%	22.5%	20.1%	19.1%	22.0%	22.6%
Interest Expense	$65M	$87M	$61M	$72M	$71M	$67M	$55M	$63M
Income Before Tax	$1.1B	$977M	$1.3B	$1.1B	$655M	$1.1B	$1.4B	$1.2B
Tax Expense	$176M	$159M	$229M	$175M	$100M	$168M	$176M	$206M
Net Income	$907M	$818M	$1.1B	$954M	$555M	$908M	$1.2B	$1.0B
Net Margin	15.8%	14.1%	16.6%	16.6%	9.3%	15.0%	17.5%	17.3%
EPS (Diluted)	$1.22	$1.12	$1.49	$1.32	$0.77	$1.27	$1.68	$1.45
EBITDA	$1.7B	$1.7B	$2.0B	$1.8B	$1.3B	$1.8B	$2.1B	$1.5B
Shares Outstanding	742M	729M	737M	721M	719M	714M	711M	711M

DHR NYSE